RxDoctor Payments Data

Neal Bhatia, MD

Dermatology · San Diego, CANPI 1255349288

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,555,260 of the $2,486,105 with a category attached, or 62.6%. It is spread thinly across 59 manufacturers, the largest accounting for just 11.8%. Among dermatology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,486,105in general payments, 2019–2025

Across 3,272 payments — averaging $759.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$293K
  • AbbVie$261K
  • Sanofi$242K
  • Pfizer$230K
  • E.r. Squibb & Sons, L.L.C.$223K
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$187K
  • plus $1.1M from 53 others
$2,615,162in research payments, 2019–2025

Across 666 payments — averaging $3926.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • E.r. Squibb & Sons, L.L.C.$335K
  • AbbVie$280K
  • Regeneron$268K
  • Eli Lilly$243K
  • Aclaris Therapeutics, Inc.$200K
  • Takeda Pharmaceuticals U.S.A., Inc.$176K
  • plus $1.1M from 22 others

What the payments were for

  • Consulting fees$630,69925%
  • Speaking & faculty fees$1,555,26063%
  • Travel & lodging$169,7487%
  • Food & beverage$98,9014%
  • Education$31,3801%
  • Gifts$1170%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sun Pharmaceutical Industries Inc.349$292,700
AbbVie(2 entities)256$260,944
Sanofi236$241,923
Pfizer173$229,860
E.r. Squibb & Sons, L.L.C.281$222,994
Ortho Dermatologics, A Division Of Bausch Health US, LLC259$187,416
Regeneron Healthcare Solutions, Inc.187$158,232
LEO Pharma Inc.183$143,990
Almirall LLC108$107,988
Incyte Corporation133$73,965
Arcutis Biotherapeutics, Inc.124$67,563
Boehringer Ingelheim49$65,932
Galderma Laboratories, L.p.106$63,780
Novartis100$63,702
Biofrontera Inc.65$59,511
UCB, Inc.133$45,260
VYNE Pharmaceuticals Inc.42$43,549
Lilly USA, LLC58$32,266
EPI Health, LLC43$23,211
Boehringer Ingelheim International GmbH7$17,502
LNHC, Inc17$14,223
Dermavant Sciences, Inc.63$12,552
Journey Medical Corporation24$9,793
Stemline Therapeutics Inc.8$8,949
DUSA Pharmaceuticals, Inc.3$6,042
Verrica Pharmaceuticals Inc.27$5,876
Janssen Scientific Affairs, LLC11$5,822
Johnson & Johnson(2 entities)73$3,081
Sanofi US Services Inc.1$2,870
Sensus Healthcare, Inc.3$2,665
Amgen38$1,727
Organon14$1,539
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$1,400
Astrazeneca UK Limited1$1,000
Sanofi-aventis U.S. LLC26$949
Takeda Pharmaceuticals U.S.A., Inc.8$896
Kowa Pharmaceuticals America, Inc.1$750
Abbott11$718
Promius Pharma LLC3$561
Bristol Myers Squibb4$337
Dermira, Inc.9$301
Aclaris Therapeutics, Inc.9$289
Zerigo Health, Inc.1$250
Chiesi USA, Inc.4$169
ANI Pharmaceuticals, Inc.2$156
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$156
Blueprint Medicines Corporation3$121
Sandoz1$120
Encore Dermatology Inc.1$120
Avita Medical Americas, LLC2$95
Solta Medical, A Division Of Bausch Health US, LLC1$47
Glenmark Therapeutics Inc.1$47
Eli Lilly1$45
Mayne Pharma Commercial LLC1$42
Botanix SB Inc1$33
Merz North America, Inc.1$22
Krystal Biotech Inc1$19
Genentech USA, Inc.1$18
Strata Skin Sciences, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,486,105 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California

Medicare billing

Part B allowed, 2024
$17,014
Medicare patients
53
Services billed
179

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →